1. Home
  2. KPTI vs CMCM Comparison

KPTI vs CMCM Comparison

Compare KPTI & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.67

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$6.14

Market Cap

188.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
CMCM
Founded
2008
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
188.7M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
KPTI
CMCM
Price
$5.67
$6.14
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$15.33
N/A
AVG Volume (30 Days)
1.2M
32.8K
Earning Date
05-11-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
$14.27
Revenue Next Year
$46.62
$39.26
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.51
$3.28
52 Week High
$10.99
$9.44

Technical Indicators

Market Signals
Indicator
KPTI
CMCM
Relative Strength Index (RSI) 31.61 36.89
Support Level $5.60 $5.66
Resistance Level $6.96 $7.05
Average True Range (ATR) 0.88 0.40
MACD -0.38 -0.14
Stochastic Oscillator 15.88 0.53

Price Performance

Historical Comparison
KPTI
CMCM

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: